Hoxton Planning & Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
3,687
+63
+2% +$5.62K 0.1% 151
2026
Q1
$260K Sell
3,624
-135
-4% -$10.4K 0.08% 183
2025
Q4
$298K Buy
3,759
+2
+0.1% +$158 0.09% 159
2025
Q3
$283K Sell
3,757
-620
-14% -$42.5K 0.09% 161
2025
Q2
$302K Sell
4,377
-317
-7% -$20.8K 0.1% 155
2025
Q1
$318K Buy
+4,694
New +$281K 0.12% 143
2024
Q4
Sell
-4,108
Closed -$258K 210
2024
Q3
$258K Buy
4,108
+142
+4% +$8.28K 0.1% 171
2024
Q2
$234K Sell
3,966
-25
-0.6% -$1.56K 0.11% 140
2024
Q1
$318K Buy
3,991
+341
+9% +$26K 0.15% 112
2023
Q4
$288K Sell
3,650
-1,598
-30% -$114K 0.15% 111
2023
Q3
$366K Sell
5,248
-275
-5% -$19.5K 0.24% 84
2023
Q2
$382K Sell
5,523
-95
-2% -$6.76K 0.24% 87
2023
Q1
$417K Sell
5,618
-854
-13% -$71.6K 0.23% 88
2022
Q4
$603K Buy
+6,472
New +$625K 0.32% 64

Other funds holding CVS

Hoxton Planning & Management's CVS Position: Q2 2026 in Review

Hoxton Planning & Management increased its CVS Health (CVS) stake by 1.7% in Q2 2026, buying an estimated $5.62K and bringing the position to 3,687 shares worth $381K. The position accounts for 0.1% of the portfolio, ranked #151.

Hoxton Planning & Management first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $603K in Q4 2022. 348 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Hoxton Planning & Management held 3,687 shares of CVS Health worth $381K as of Q2 2026.
  • Hoxton Planning & Management bought 63 CVS Health shares in Q2 2026, an estimated $5.62K.
  • CVS Health made up 0.1% of Hoxton Planning & Management's portfolio in Q2 2026, its #151 holding.
  • Hoxton Planning & Management first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Hoxton Planning & Management's CVS Health position peaked at $603K in Q4 2022.
  • 348 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.